---
figid: PMC7586293__ac0c02793_0002
figtitle: '|Central metabolic pathways are driven not only by post-transcriptional
  changes but also by the adaptation of protein concentration upon the induction of
  insulin resistance'
organisms:
- NA
pmcid: PMC7586293
filename: ac0c02793_0002.jpg
figlink: pmc/articles/PMC7586293/figure/fig2/
number: F2
caption: '|Central metabolic pathways are driven not only by post-transcriptional
  changes but also by the adaptation of protein concentration upon the induction of
  insulin resistance. Here, (a) displays the tricarboxylic acid cycle and (b) the
  insulin signaling pathway in OP9 preadipocytes after a 24 h treatment of TNFα (10
  ng/mL) (2), 48 h treatment of rosiglitazone (1 μM) (3), or an initial 48 h rosiglitazone
  plus a 24 h TNFα (4) treatment. DMSO (0.01%) serves as control (1). Bar graphs display
  n = 3 biological replicates; error distribution is provided in the Supporting Information
  (Figures S2 and S3).'
papertitle: 'Simple Targeted Assays for Metabolic Pathways and Signaling: A Powerful
  Tool for Targeted Proteomics.'
reftext: Dominik Kopczynski, et al. Anal Chem. 2020 Oct 20;92(20):13672-13676.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8823916
figid_alias: PMC7586293__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Danio rerio
redirect_from: /figures/PMC7586293__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7586293__ac0c02793_0002.html
  '@type': Dataset
  description: '|Central metabolic pathways are driven not only by post-transcriptional
    changes but also by the adaptation of protein concentration upon the induction
    of insulin resistance. Here, (a) displays the tricarboxylic acid cycle and (b)
    the insulin signaling pathway in OP9 preadipocytes after a 24 h treatment of TNFα
    (10 ng/mL) (2), 48 h treatment of rosiglitazone (1 μM) (3), or an initial 48 h
    rosiglitazone plus a 24 h TNFα (4) treatment. DMSO (0.01%) serves as control (1).
    Bar graphs display n = 3 biological replicates; error distribution is provided
    in the Supporting Information (Figures S2 and S3).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SORBS1
  - SH2B2
  - CISH
  - PTPN1
  - INPPL1
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - ACACA
  - FAS
  - FASN
  - RHEB
  - RHEBP1
  - MDH2
  - ACO2
  - KRAS
  - HRAS
  - NRAS
  - PPA1
  - NPY4R
  - NPY4R2
  - GSK3B
  - FH
  - IDH1
  - IDH2
  - FOXD1
  - MTOR
  - RPTOR
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - NF2
  - OGDH
  - CALM2
  - CALM3
  - PICALM
  - SNAP91
  - CALM1
  - GYS1
  - GYS2
  - TNF
  - PYGB
  - PYGL
  - PYGM
  - sorbs1
  - sh2b2
  - ptpn1
  - acaca
  - fas
  - rheb
  - rhebl1
  - aco2
  - rab1ab
  - parapinopsina
  - gsk3ba
  - fh
  - foxd1
  - foxd2
  - mtor
  - rptor
  - ogdha
  - tnfa
  - tnfb
  - Glucose
  - Pyruvate
  - Citrate
  - ACACA
  - Rosiglitazon
---
